MedPath

A randomized, double-blind, placebo-controlled study of effect of green tea on lifestyle-related disease preventio

Not Applicable
Conditions
metabolic syndrome
Registration Number
JPRN-UMIN000001722
Lead Sponsor
Kakegawa Research Council for application of green tea in preventive medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

1) Individuals with a medical record of heart failure or cardiac infarction. 2) Individuals judged to have atrial fibrillation, Irregular Heart Beat, hepatic damage, kidney damage, cerebrovascular accident, rheumatism, diabetes mellitus, lipid disorder and/or anemia. 3) Individuals with a medical record of allergy to food and drug. 4) Pregnant women, or women with intending to become pregnant, and lactating women. 5) Individuals judged by the doctor to be unsuitable.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1) body weight 2) HbA1c 3) LDL-cholesterol
Secondary Outcome Measures
NameTimeMethod
1) Blood pressure, fat percentage, waist, BMI 2) FBS, insulin 3) Serum total cholesterol, HDL-cholesterol, triglycerides 4) Serum amyloid protein A, high sensitive C_reactive protein 5) Adiponectin, TNF-alfa, urine 8-OHdG
© Copyright 2025. All Rights Reserved by MedPath